Competitive Exams: Current Affairs 2011: Banned medicines

Banned Medicines

The Central Government has prohibited six drugs on the recommendations of the Expert Committee constituted by

DTAB in view of the safety issues involved in the use of these drugs by a Gazette Notification dated 10.02. 2011 with immediate effect. The names of these drugs along with the brief reasons for their ban are furnished below:

  1. Nimesulide formulations in children below 12 years of age-Nimesulide containing products are not permitted in many countries in children under 12 years of age. The drug has been considered to be hepatotoxic and children are considered more susceptible to hepatotoxicity.

  2. Cisapride and its formulations for human use-Use of this drug is reported to be associated with increased risk of serious cardiac arrhythmia.

  3. Phenylpropanolamine and its formulations for human use-Use of this drug is associated with risk of hypertensive episodes like cardiac congestive failures and hemorrhagic strokes.

  4. Human Placental Extract and its formulations for human use-There is no clear evidence of efficacy of this drug in most of the conditions and there are safety concerns like transmission of blood borne infections, immunoreactions and unwanted exposure to hormones associated with its use.

  5. Sibutramine and its formulations for human use-Use of this drug is associated with increased risk of cardiovascular events such as heart attack and stroke.

  6. R-Sibutramine and its formulations for human use-Use of this drug is associated with increased risk of cardiovascular events such as heart attack and stroke.

Courtesy: The Hindu and Times of India